Disease Info Card

Glucose-6-phosphate Transport Defect

Information about Glucose-6-phosphate Transport Defect: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Glucose-6-phosphate Transport Defect

Most recent studies have shown that Glucose-6-phosphate Transport Defect shares some biological mechanisms with bacterial-infections, crohn-disease, cyclic-neutropenia, glycogen-storage-disease, glycogen-storage-disease-type-i, hemorrhage, hepatomegaly, hyperlipidemia, hyperuricemia, hypoglycemia, infective-disorder, inflammation, inflammatory-bowel-diseases, intestinal-diseases, malignant-neoplasms, metabolic-diseases, neutropenia-chronic, qualitative-abnormality-of-granulocyte, severe-congenital-neutropenia, storage-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Glucose-6-phosphate Transport Defect, and have been seen in publications frequently: Antiport, Chemotaxis, Energy Homeostasis, Gluconeogenesis, Glucose Homeostasis, Glucose-6-phosphate Transport, Glycosylation, Inflammatory Response, Lymphocyte Activation, Membrane Depolarization, Pathogenesis, Phagocytosis, Respiratory Burst, Reverse Transcription, Transport

Quite a number of genes have been found to play important roles in Glucose-6-phosphate Transport Defect, such as ATP8A2, CALCA, CSF2, CSF3, ELANE, G6PC, G6PC3, IL2, IL4, ITGB3, SELL, SF3B1, SLC37A4, VDAC1, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.